Neurontin Class Action V. Pfizer Dismissed
A federal judge has dismissed a consolidated class action accusing Pfizer Inc. of a scheme to use patent litigation to delay generic competition for the epilepsy drug Neurontin, after the end-payor...To view the full article, register now.
Already a subscriber? Click here to view full article